CUAMC
China Universal Asset Management Company’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $222K | Buy |
9,300
+18
| +0.2% | +$430 | 0.02% | 301 |
|
|
2025
Q1 | $231K | Sell |
9,282
-508
| -5% | -$12.6K | 0.02% | 301 |
|
|
2024
Q4 | $184K | Buy |
9,790
+918
| +10% | +$17.3K | 0.02% | 333 |
|
|
2024
Q3 | $134K | Buy |
8,872
+3,404
| +62% | +$51.2K | 0.01% | 332 |
|
|
2024
Q2 | $156K | Sell |
5,468
-3,462
| -39% | -$99K | 0.02% | 269 |
|
|
2024
Q1 | $261K | Buy |
8,930
+3,557
| +66% | +$104K | 0.03% | 259 |
|
|
2023
Q4 | $181K | Buy |
5,373
+4,188
| +353% | +$141K | 0.04% | 214 |
|
|
2023
Q3 | $36.4K | Buy |
1,185
+583
| +97% | +$17.9K | 0.01% | 250 |
|
|
2023
Q2 | $24.1K | Sell |
602
-21
| -3% | -$841 | 0.01% | 252 |
|
|
2023
Q1 | $25.4K | Buy |
623
+157
| +34% | +$6.41K | 0.01% | 199 |
|
|
2022
Q4 | $18K | Buy |
466
+37
| +9% | +$1.43K | 0.01% | 182 |
|
|
2022
Q3 | $23K | Buy |
+429
| New | +$23K | 0.01% | 147 |
|